section name header

Indications ⬇

REMS


Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Interactions ⬆ ⬇

Noted primarily for PO and IV use, but should be considered for topical use

Availability ⬆ ⬇

(Generic available)

Route/Dosage ⬆ ⬇

US Brand Names ⬆ ⬇

Protopic

Action ⬆ ⬇

  • Inhibits T-lymphocyte activation.
Therapeutic effects:
  • Improvement in signs/symptoms of atopic dermatitis.

Classifications ⬆ ⬇

Therapeutic Classification: Immunosuppressant agents

Pharmacokinetics ⬆ ⬇

Absorption: Minimal following topical use.

Distribution: Unknown.

Protein Binding: 99%.

Metabolism/Excretion: Unknown.

Half-Life: Unknown.

Time/Action Profile ⬆ ⬇

(immunosuppression)

ROUTEONSETPEAKDURATION
Topical‡unknown1–2 wkunknown

‡Improvement in atopic dermatitis.

Patient/Family Teaching ⬆ ⬇

Pronunciation ⬆ ⬇

ta-KROE-li-mus

Code ⬆

NDC Code